Why do most novel antimicrobials that are efficacious against drug resistant infections request approval from regulators on the basis of non-inferiority clinical trials?

Question

Answer

Because there already are too many drug-resistant infections to show superiority

Answer

Because they do not really have clear advantages over current treatments

Answer

Because there are not enough drug-resistant infections yet to prove superiority

Answer

Because it is easier to design a non-inferiority trial

Crowdly

Why do most novel antimicrobials that are efficacious against drug resistant inf...

Want instant access to all verified answers on learning.monash.edu?